Clinical Trial Update: Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%) [Phase 2]

View source ↗

Summary

Phase 2 pilot study assessing safety and efficacy of propranolol 0.2% eye drops for retinopathy of prematurity; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Drugs mentioned

• propranolol 0.2% eye drops (propranolol)

Snippet

Sponsor: Meyer Children's Hospital IRCCS | Conditions: Retinopathy of Prematurity | Phase 2 | Status: COMPLETED